Expert Ratings For NewAmsterdam Pharma - Nasdaq

Sep 23, 2024 · 4 analysts have shared their evaluations of NewAmsterdam Pharma (NASDAQ:NAMS) during the recent three months, ... Expert Ratings For NewAmsterdam Pharma September 23, 2024 — 09:00 am EDT ...

CouponFollow Extension

$39.83
OFF

Where NewAmsterdam Pharma Stands With Analysts - Nasdaq

3 weeks from now

Dec 30, 2024 · In the assessment of 12-month price targets, analysts unveil insights for NewAmsterdam Pharma, presenting an average target of $39.83, a high estimate of $48.00, …

nasdaq.com

59%
OFF

NewAmsterdam Pharma Company N.V. (NAMS) Analyst Ratings

3 weeks from now

NewAmsterdam Pharma Company N.V. (NAMS) NASDAQ: NAMS · Real-Time Price · USD. Watchlist Compare. 26.11 +0.41 (1.59%) Jan 2, 2025, 12:39 PM EST - Market open. ... Up to …

stockanalysis.com

$32.67
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Stock, Analyst Ratings …

3 weeks from now

Jan 1, 2019 · NewAmsterdam Pharma Co NV has a consensus price target of $32.67 based on the ratings of 11 analysts. The high is $48 issued by HC Wainwright & Co. on January 14, …

benzinga.com

72%
OFF

NewAmsterdam Pharma Company N.V. (NAMS) Stock Forecast

3 weeks from now

Nov 24, 2022 · NewAmsterdam Pharma Company N.V. (NAMS) NASDAQ: NAMS · Real-Time Price · USD. Watchlist Compare. 23.60 +0.40 (1.72%) Jan 24, 2025, 4:00 PM EST - Market …

stockanalysis.com

$39.80
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Receives $39.80

3 weeks from now

Jan 20, 2025 · NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) has received a consensus rating of "Buy" from the six brokerages that are currently covering the stock, …

marketbeat.com

$45.00
OFF

Jefferies Sticks To Their Buy Rating For NewAmsterdam Pharma …

3 weeks from now

Nov 19, 2024 · Jefferies analyst Dennis Ding maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today and set a price target of $45.00. The company’s …

businessinsider.com

$48.00
OFF

Promising Outlook For NewAmsterdam Pharma: Ed Arce’s Buy …

3 weeks from now

Jan 14, 2025 · Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report), retaining the price target of $48.00. Discover …

businessinsider.com

1%
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 4.1

3 weeks from now

1 day ago · NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) traded up 4.1% during mid-day trading on Friday . The company traded as high as $23.24 and last traded at $22.67. …

marketbeat.com

FAQs about Expert Ratings For NewAmsterdam Pharma - Nasdaq Coupon?

Should you buy newamsterdam Pharma (NAMS – research report)?

Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report), retaining the price target of $48.00. Ed Arce’s rating is based on the promising developments and strategic plans of NewAmsterdam Pharma, particularly regarding their lead product candidate, obicetrapib. ...

Should you buy newamsterdam pharma company (Ding) stock?

Ding covers the Healthcare sector, focusing on stocks such as Amicus, Arbutus Biopharma, and Assembly Biosciences. According to TipRanks, Ding has an average return of -3.8% and a 42.55% success rate on recommended stocks. NewAmsterdam Pharma Company has an analyst consensus of Strong Buy, with a price target consensus of $37.67. ...

Is newamsterdam Pharma A listed company?

Listed company to be named NewAmsterdam Pharma Company N.V. -- -- Ordinary shares and warrants to commence trading on the Nasdaq Capital Market under the ticker symbols “NAMS” and “NAMSW,” respectively on November 23 – ...